|
Brain Tumor News : 2007
June 19, 2007 – Innovative Clinical Trial Begins for Patients Diagnosed with Primary Glioma
The Tug McGraw Foundation offers this exciting news about a groundbreaking new clinical trial currently underway in conjunction with the National Cancer Institute. This trial explores the impact of alternative and dietary interventions along with other compatible therapies in the treatment of brain tumors.
Read the complete article
May 3, 2007 – Distress Levels and Cancer-Related Items of Concern in Brain Tumor Population
Distress is a major concern for cancer patients. Patients with brain tumors are particularly at risk for elevated levels of stress because of the severe functional, cognitive and neuropsychological symptoms of the disease. A study at the Tug McGraw Center at Duke is working to identify the extent and causes of this kind of distress.
Read the complete article
February 23, 2007 – Cancer Drug Can Extend Survival in Patients with
Deadly Brain Tumors
Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.
Read the complete article
February 2, 2007 – You Can Manage Fatigue
If you’ve recently been diagnosed with a brain tumor, you might also find yourself wrestling with a lowered energy level or consistent fatigue. This recent article titled “You Can Manage Fatigue” shares some insights on how to identify and address some of its contributing factors.
Read the complete article
February 2, 2007 – Thinking with Brain Tumors
There are many different reasons why patients with brain tumors develop cognitive problems or personality changes. This article from the Preston Robert Tisch Brain Tumor Center at Duke explores how the location, size, and type of brain tumor or treatment can impact some of these changes.
Read the complete article
January 15, 2007 – From the Research Front: Stem Cells and Brain Tumors
Stem cells are increasingly implicated in maintaining certain cancers. Studies of an intractable type of brain tumor provide hints as to why such cells may underlie the tumors' resistance to therapy.
Read the complete article
|